MEETINGS - New advances in cardiology and vascular therapies (US) November 2001:
This article was originally published in Clinica
Executive Summary
IHS Health Group is to present New advances in cardiology and vascular therapies on November 12 2001 at Disney's Grand Californian Resort Anaheim, California. It will address industry advances and market opportunities in invasive cardiology and endovascular therapies, endoluminal techniques and stent applications, procedures and management and restenosis prevention. Further details on tel: +1 800 525 5539; fax: +1 303 705 4222; email: [email protected] www.ihshealthgroup.com
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.